Idt Australia logo
IDT
Pharmaceuticals, Biotechnology & Life Sciences

IDT Australia

Short interest
0.11%
+0.10 pp 30d
as of 21 May 2026
Reported shorts
449.6K
Shares on issue
427.426M

IDT Australia (IDT) company profile

Profile, insiders and operations

Company

AI-generated research profile of IDT Australia

Pharmaceuticals
CDMO
API Manufacturing
Sterile Injectables
Contract Manufacturing

IDT Australia is a Melbourne-based Contract Development and Manufacturing Organisation (CDMO) with over 50 years of experience. They offer end-to-end services from pre-clinical development to commercial-scale supply, covering active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Their cGMP facility supports oral medicines and sterile injectables, serving both local and international markets.

Director trades

18 trades recorded

DateDirectorTypeSharesPriceValue
2026-08-24Unknown Director
buy
---
2026-08-10Unknown Director
buy
---
2026-08-10Unknown Director
buy
---
2026-08-10Unknown Director
buy
---
2026-08-07Jane Ryan
sell
3,000,000--
2026-08-07Geoffrey Sam
sell
3,000,000--
2026-08-07Mark Simari
sell
6,000,000--
2026-05-12Geoffrey Sam
buy
125,000$0.039$4,875
2026-05-06Unknown Director
buy
---
2026-04-30Geoffrey Sam
buy
489,695$0.041$19,904.8
2026-03-27Unknown Director
buy
---
2026-03-24Mark Simari
buy
325,000$0.045$14,557.19
2026-02-23Unknown Director
buy
---
2026-02-18Mark Simari
buy
501,936$0.048$24,092.93
2025-12-09Unknown Director
buy
---
2025-12-04Geoffrey Sam
buy
98,039$0.052$5,098.03
2025-04-14Geoffrey Sam
buy
---
2025-04-10Geoffrey Sam
buy
248,632$0.100$24,821.97

IDT intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required